Xtant Medical Holdings (XTNT) Income from Continuing Operations (2010 - 2025)
Xtant Medical Holdings (XTNT) reported Income from Continuing Operations of 57000.0 for Q4 2025, up 101.8% year-over-year from 28245.66 in Q4 2024, and down 95.64% quarter-over-quarter from 1308000.0 in Q3 2025.
Xtant Medical Holdings (XTNT) Income from Continuing Operations (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of Income from Continuing Operations data on file, last reported at 57000.0 in Q4 2025.
- Income from Continuing Operations for Q4 2025 came in at 57000.0, up 101.8% year-over-year; the trailing twelve-month figure through Dec 2025 was 4973000.0 (up 130.23% YoY), and the FY2025 annual result was 4973000.0, up 130.23% from the prior year.
- Income from Continuing Operations retreated to 57000.0 in Q4 2025 per XTNT's latest filing, from 1308000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 9231000.0 in Q3 2023 and troughed at 5024000.0 in Q3 2024.
- A 5-year average of 1212250.0 and a median of 2134000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations tumbled 7531.03% in 2022, then soared 492.31% in 2023.
- A 5-year view of Income from Continuing Operations shows it stood at 2377000.0 in 2021, then increased by 7.07% to 2209000.0 in 2022, then slumped by 94.79% to 4303000.0 in 2023, then gained by 26.45% to 3165000.0 in 2024, then jumped by 101.8% to 57000.0 in 2025.
- Business Quant data shows XTNT's Income from Continuing Operations at 57000.0 in Q4 2025, 1308000.0 in Q3 2025, and 3550000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Xtant Medical Holdings | 60.86 Mn | 43.54 Mn | 17.75 Mn | 57,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57,000.00 |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | -3.17 Mn |
| Sep 30, 2024 | -5.02 Mn |
| Jun 30, 2024 | -3.86 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Dec 31, 2023 | -4.30 Mn |
| Sep 30, 2023 | 9.23 Mn |
| Jun 30, 2023 | -2.19 Mn |
| Mar 31, 2023 | -2.08 Mn |
| Dec 31, 2022 | -2.21 Mn |
| Sep 30, 2022 | -2.35 Mn |
| Jun 30, 2022 | -1.71 Mn |
| Mar 31, 2022 | -2.21 Mn |
| Dec 31, 2021 | -2.38 Mn |
| Sep 30, 2021 | -1.80 Mn |
| Jun 30, 2021 | -733,000.00 |
| Mar 31, 2021 | -29,000.00 |